[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338162-105":59,"doc-detail-338162-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","pan-cancer-analysis-of-m1a-writer-gene-rrp8-implications-for-immune-infiltration-and-prognosis-in-human-cancers","Pan-cancer analysis of m1A writer gene RRP8 - implications for immune infiltration and prognosis in human cancers","","Background: Ribosomal RNA Processing 8 (RRP8) is linked to RNA modification and has been reported to contribute to multiple tumor types, but its role across cancers remains insufficiently characterized. Methods: The study analyzes public databases to evaluate RRP8 functions, including associations with pan-cancer prognosis, heterogeneity, stemness, immune checkpoint genes, and immune-cell infiltration. Drug-response sensitivity is assessed using GDSC and CTRP. Results: RRP8 differs between tumor and normal tissue and relates to prognosis, heterogeneity, stemness, immune infiltration, and TP53 mutations. Conclusion: RRP8 may function as a prognostic biomarker and therapeutic target across diverse cancers.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pan-cancer-analysis-of-m1a-writer-gene-rrp8-implications-for-immune-infiltration-and-prognosis-in-human-cancers/338162/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pan-cancer-analysis-of-m1a-writer-gene-rrp8-implications-for-immune-infiltration-and-prognosis-in-human-cancers/338162.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is RRP8 and why is it important in this pan-cancer study?","Question",{"text":112,"@type":113},"RRP8 (Ribosomal RNA Processing 8) is a gene associated with RNA modification. The study focuses on clarifying its biological importance across human cancers and whether it relates to clinical outcomes and immune features.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the study evaluate the relationship between RRP8 and cancer biology?",{"text":117,"@type":113},"It examines correlations using public databases, including pan-cancer prognosis, tumor heterogeneity, stemness, immune checkpoint gene links, and immune-cell infiltration. It also uses GDSC and CTRP to assess sensitivity to small-molecule drugs.",{"name":119,"@type":110,"acceptedAnswer":120},"What key findings connect RRP8 with prognosis and the tumor immune environment?",{"text":121,"@type":113},"RRP8 shows differential expression between tumor and normal samples, is linked to prognosis in multiple cancers (e.g., ACC and KICH), and correlates with tumor heterogeneity and stemness markers. It is also positively associated with tumor-infiltrating cells, with TP53 as a predominant mutated gene.",{"name":123,"@type":110,"acceptedAnswer":124},"What do the conclusions suggest about clinical use of RRP8?",{"text":125,"@type":113},"The results suggest RRP8 could serve as a potential prognostic marker and a therapeutic target across various cancer types, supported by its associations with immune infiltration and cancer outcomes.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},338162,1790906891,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":36,"preview_page_count":19,"preview_urls":149},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Analysis  \nPan‑cancer analysis of m1A writer gene RRP8: implications for immune infiltration and prognosis in human cancers  \nZhihui Huang1,2,8 · Koo Han Yoo3 · Duohui Li4 · Qingxin Yu5,9 · Luxia Ye6 · Wuran Wei7  \nReceived: 12 June 2024 / Accepted: 2 September 2024  \n© The Author(s) 2024 OPEN  \nAbstract  \nBackground Ribosomal RNA Processing 8 (RRP8) is a gene associated with RNA modification and has been implicated in the development of several types of tumors in recent research. Nevertheless, the biological importance of RRP8 in pan-cancer has not yet been thoroughly and comprehensively investigated.  \nMethods In this study, we conducted an analysis of various public databases to investigate the biological functions of RRP8 . Our analysis included examining its correlation with pan-cancer prognosis, heterogeneity, stemness, immune checkpoint genes, and immune cell infiltration. Furthermore, we utilized the GDSC and CTRP databases to assess the sensitivity of RRP8 to small molecule drugs.  \nResults Our findings indicate that RRP8 exhibits differential expression between tumor and normal samples, particularly impacting the prognosis of various cancers such as Adrenocortical carcinoma (ACC) and Kidney Chromophobe (KICH) . The expression of RRP8 is intricately linked to tumor heterogeneity and stemness markers. Additionally, RRP8 shows a positive correlation with the presence of tumor-infiltrating cells, with TP53 being the predominant mutated gene in these malignancies.  \nConclusion Our findings suggest that RRP8 may serve as a potential prognostic marker and therapeutic target in a variety of cancer types.  \nKeywords Pan cancer · RNA 1-methylcytosine · Ribosomal RNA Processing 8 · Tumor-infiltrating cells  \nAbbreviations  \nm6A N6-methyladenosine  \nm5C 5-Methylcytosine  \nm1A N1-methyladenosine  \nRRP8 Ribosomal RNA Processing 8  \nTCGA The Cancer Genome Atlas  \nSupplementary Information The online version contains supplementary material available at [https://doi.org/10.1007/s12672-024-](https://doi.org/10.1007/s12672-024-)[ ](https://doi.org/10.1007/s12672-024-)[01299-0](01299-0.)[.](01299-0.)  \n* Duohui Li, [2860263085@qq.com](2860263085@qq.com); * Qingxin Yu, [qingxinyu0220@163.com](qingxinyu0220@163.com); * Luxia Ye, [ylx941016@163.com](ylx941016@163.com); * Wuran Wei,  \n[weiwuranwch@126.com](weiwuranwch@126.com); Zhihui Huang, [624539501@qq.com](624539501@qq.com); Koo Han Yoo, [yookoohan@khu.ac.kr |](yookoohan@khu.ac.kr |1Operating)[1](yookoohan@khu.ac.kr |1Operating)[Operating](yookoohan@khu.ac.kr |1Operating) Room, West China Hospital,  \nSichuan University, Chengdu, China. 2West China School of Nursing, Sichuan University, Chengdu, China. 3Department of Urology, Kyung Hee University, Seoul, South Korea. 4Department of Pharmacy Management, Anqing Municipal Hospital, Anqing 246000, Anhui, China. 5Department of Pathology, Ningbo Clinical Pathology Diagnosis Center, Ningbo 315211, Zhejiang, China. 6Department of Public Research Platform, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China. 7Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China. 8West China Tianfu Hospital, Sichuan University, Chengdu, China. 9Department of pathology, Ningbo Medical Centre Lihuili Hospital, Ningbo, China.  \nDiscover Oncology  \n(2024) 15:437  \n| [https://doi.org/10.1007/s12672-024-01299-0](https://doi.org/10.1007/s12672-024-01299-0)  \nOS  \nPFI  \nDFS  \nDSS  \nDNAss  \nDMPss  \nEHNss  \nRNAss  \nEREG-METHss  \nEREG-METHss  \nTMB  \nMATH  \nLOH NEO  \nHRD  \nMSI  \nACC  \nKICH  \nLGG  \nLIHC  \nKIPAN  \nKIRP  \nGBMLGG  \nLUSC COADPCPG  \nTHYM  \nNK  \nSTAD  \nGDSC  \nCTRP  \nPVR  \nGSEA  \nKEGG  \nMAPK  \nECM-receptor  \nOverall survival Progression-free interval Disease-free survival Disease-specific survival DNA methylation based  \nDifferentially methylated probes-based Enhancer elements/DNA methylation-based RNA expression-based  \nEpigenetically regulated DNA methylation-based  \nEp","cbCairOxxQaPDVrh","https://ap.wps.com/l/cbCairOxxQaPDVrh","pdf",7918860,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is RRP8 and why is it important in this pan-cancer study?\",\"answer\":\"RRP8 (Ribosomal RNA Processing 8) is a gene associated with RNA modification. The study focuses on clarifying its biological importance across human cancers and whether it relates to clinical outcomes and immune features.\"},{\"question\":\"How does the study evaluate the relationship between RRP8 and cancer biology?\",\"answer\":\"It examines correlations using public databases, including pan-cancer prognosis, tumor heterogeneity, stemness, immune checkpoint gene links, and immune-cell infiltration. It also uses GDSC and CTRP to assess sensitivity to small-molecule drugs.\"},{\"question\":\"What key findings connect RRP8 with prognosis and the tumor immune environment?\",\"answer\":\"RRP8 shows differential expression between tumor and normal samples, is linked to prognosis in multiple cancers (e.g., ACC and KICH), and correlates with tumor heterogeneity and stemness markers. It is also positively associated with tumor-infiltrating cells, with TP53 as a predominant mutated gene.\"},{\"question\":\"What do the conclusions suggest about clinical use of RRP8?\",\"answer\":\"The results suggest RRP8 could serve as a potential prognostic marker and a therapeutic target across various cancer types, supported by its associations with immune infiltration and cancer outcomes.\"}]","Pan-cancer analysis of m1A writer gene RRP8 - implications for immune infiltration and prognosis in human cancers | PDF",1790022308,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/37d47bf1d6b241d7619cdb39e307bfe3.webp",983,1305,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/17482f37bc5529c1644bba9a1b1869aa.webp",982,1304,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7620999a4c8ef5e0bf01105e2a891e4b.webp",981,1303,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c33c18002e2a798fbbd21d39e1649f9.webp",980,1301]